Tag: pathology
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC...
By Sylvie Lantuejoul, MD, PhD, and Mari Mino-Kenudson, MD
Posted: April 16, 2020
Immune checkpoint inhibitors (ICI), which target the PD-1/PD-L1 axis with the aim of...
Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s...
By Lynette M. Sholl, MD, and John W. Longshore, PhD, FACMG
Posted: February 12, 2020
The profound impact of immunotherapy in patients with lung cancer has...
PD-L1 in Cytology Specimens
By Anjali Saqi, MD, MBA; Deepali Jain, MD, FIAC; Lukas Bubendorf, MD; Keith Kerr, MB, ChB, MRCPath, FRCPath, FRCP(Ed); and Andre Moreira, MD, PhD
Posted:...
